Skip to main content

FDA recall, , Low risk

ImprimisRx NJ Povidone Iodine and Proparacaine Ophthalmic Solution

The ophthalmic solution is subpotent.

What happened

ImprimisRx NJ LLC of Ledgewood, New Jersey, is recalling Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL per dropper bottle, For Office Use Only, because the product is subpotent. The recall began on August 24, 2026, and was added to the FDA's Enforcement Report on September 8, 2026.

The product was distributed nationwide in the USA. The recalled item is identified as Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. The recall involves 772 bottles.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

Match the NDC and lot code listed under your product.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. Povidone Iodine 1.25% Proparacaine HCl 0.5% Ophthalmic Solution

    NDC
    • 71384-732-10
    Lot code
    • 26JAN035

Recall details

Company began the recall
Sold in

USA Nationwide

Company
ImprimisRx NJ LLCLedgewood, New Jersey
Risk

Low risk

Taking it is unlikely to cause health problems.

FDA Class III recall · How risk is rated

Event ID
99756
Recall number
D-0835-2026
Quantity recalled
772 bottles

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)